Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034914.xml
Osteologie 2018; 27(01): 60-61
DOI: 10.1055/s-0038-1637846
DOI: 10.1055/s-0038-1637846
DVO-Newsletter/Der Osteologe DVO und Informationen der Gesellschaft
Arbeitsgemeinschaft Knochentumoren e. V. (agkt)
Further Information
Korrespondenzadresse
Dr. med. Thomas Grünewald, Ph.D.
Max-Eder Nachwuchsgruppe für Pädiatrische Sarkombiologie
Pathologisches Institut
Medizinische Fakultät
LMU München
Thalkirchner Str. 36
80337 München
Phone: 089/2180-73716
Fax: 089/2180-73604
Publication History
Publication Date:
07 March 2018 (online)
#
-
Literatur
- 1 Coulie PG. et al. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer 2014; 14: 135-146.
- 2 Mellman I. et al. Cancer immunotherapy comes of age. Nature 2011; 480: 480-489.
- 3 Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science 2015; 348: 69-74.
- 4 Lawrence MS. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499: 214-218.
- 5 Pugh TJ. et al. The genetic landscape of high-risk neuroblastoma. Nat Genet 2013; 45: 279-284.
- 6 Tirode F. et al. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov 2014; 04: 1342-1353.
- 7 Baldauf MC. et al. Systematic identification of cancer-specific MHC-binding peptides with RAVEN. bioRxiv 193276. 2017 doi:10.1101/193276
- 8 Oberthuer A. et al. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome. Clin Cancer Res 2004; 10: 4307-4313.
- 9 Foell JL. et al. Membrane-associated phospholipase A1 beta (LIPI) Is an Ewing tumour-associated cancer/testis antigen. Pediatr Blood Cancer 2008; 51: 228-234.
Korrespondenzadresse
Dr. med. Thomas Grünewald, Ph.D.
Max-Eder Nachwuchsgruppe für Pädiatrische Sarkombiologie
Pathologisches Institut
Medizinische Fakultät
LMU München
Thalkirchner Str. 36
80337 München
Phone: 089/2180-73716
Fax: 089/2180-73604
-
Literatur
- 1 Coulie PG. et al. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer 2014; 14: 135-146.
- 2 Mellman I. et al. Cancer immunotherapy comes of age. Nature 2011; 480: 480-489.
- 3 Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science 2015; 348: 69-74.
- 4 Lawrence MS. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499: 214-218.
- 5 Pugh TJ. et al. The genetic landscape of high-risk neuroblastoma. Nat Genet 2013; 45: 279-284.
- 6 Tirode F. et al. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov 2014; 04: 1342-1353.
- 7 Baldauf MC. et al. Systematic identification of cancer-specific MHC-binding peptides with RAVEN. bioRxiv 193276. 2017 doi:10.1101/193276
- 8 Oberthuer A. et al. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome. Clin Cancer Res 2004; 10: 4307-4313.
- 9 Foell JL. et al. Membrane-associated phospholipase A1 beta (LIPI) Is an Ewing tumour-associated cancer/testis antigen. Pediatr Blood Cancer 2008; 51: 228-234.